BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8010063)

  • 1. [Characterization of a fluorouracil-resistant human gastric carcinoma cell line and its morphological behavior].
    Yue XF; Han JX; Dai ZQ; Liu MZ; Yang WY; Xu JY; Zhou JJ; Chen LJ; Zhang SY
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14 Suppl():S1-4. PubMed ID: 8010063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of a human ovarian cancer line to 5-fluorouracil associated with decreased levels of 5-fluorouracil in DNA.
    Chu E; Lai GM; Zinn S; Allegra CJ
    Mol Pharmacol; 1990 Sep; 38(3):410-7. PubMed ID: 2402230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment, characterization, and biological analysis of pancreatic adenocarcinoma cell strain SW1990/FU].
    Guo JC; Zhao YP; Liao Q; Chen G; Zhang LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):592-6. PubMed ID: 16274039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
    de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
    Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice.
    Inada T; Ichikawa A; Kubota T; Ogata Y; Moossa AR; Hoffman RM
    Anticancer Res; 1997; 17(3C):1965-71. PubMed ID: 9216653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].
    Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ
    Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil.
    Liu J; Li X; Cheng YN; Cui SX; Chen MH; Xu WF; Tian ZG; Makuuchi M; Tang W; Qu XJ
    Eur J Pharmacol; 2007 Nov; 574(1):1-7. PubMed ID: 17904544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical differences in the tumor cells of 5-fluorouracil-sensitive and -resistant strains of Ehrlich ascitic carcinoma].
    Shlemkevich MP
    Biull Eksp Biol Med; 1983 Feb; 95(2):72-4. PubMed ID: 6824782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fundamental study of combination chemotherapy with THP, 5-FU and CDDP for human KB carcinoma cell line and its multidrug resistant cell line KB-C1--usefulness of treatment with 5-FU preceding CDDP].
    Kishimoto H; Manno Y; Tanaka H; Moridera K; Urade M
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):505-9. PubMed ID: 11329785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells.
    Wang W; Cassidy J; O'Brien V; Ryan KM; Collie-Duguid E
    Cancer Res; 2004 Nov; 64(22):8167-76. PubMed ID: 15548681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
    De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
    Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript.
    Ishiguro M; Iwasaki H; Ohjimi Y; Kaneko Y
    Oncol Rep; 2004 Jun; 11(6):1169-75. PubMed ID: 15138551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Fujishima H; Nakano S; Masumoto N; Esaki T; Tatsumoto T; Kondo T; Niho Y
    Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of combination chemotherapy with 5-FU and CDDP for human gastric carcinoma transplanted into nude mice].
    Yamada T; Tanase M; Watanabe A; Sawada H; Yamada Y; Shino Y; Yamashita J; Matsuda M; Nakano H
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):43-7. PubMed ID: 9020944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line.
    Han Y; Bu LM; Ji X; Liu CY; Wang ZH
    Chin J Dig Dis; 2005; 6(2):82-6. PubMed ID: 15904426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations.
    Willson JK; Long BH; Marks ME; Brattain DE; Wiley JE; Brattain MG
    Cancer Res; 1984 Dec; 44(12 Pt 1):5880-5. PubMed ID: 6437674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
    Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
    De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
    Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.